22nd Century Group, Inc (XXII) Covered Calls

22nd Century Group, Inc. is a plant biotechnology company. The Company is focused on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding.

There are no covered calls available for 22nd Century Group, Inc.

Born To Sell's covered call screener gives you full search capabilities so you can find stocks and ETFs that make good covered call candidates.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

22nd Century Group, Inc. is a plant biotechnology company. Its proprietary technology allows for the levels of nicotine and other nicotinic alkaloids in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. The company operates its business through smoking cessation products and modified risk tobacco products segments. Its subsidiary Goodrich Tobacco is focused on commercial tobacco products and potential modified risk cigarettes; and Hercules Pharmaceuticals LLC is focused on X-22, a prescription smoking cessation aid in development. 22nd Century Group's business roots are back to February 20, 1998. The company was founded by Joseph pandolfino on September 12, 2005 and is headquartered in Clarence, NY.